News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
COLEMAN KIRK ALLEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| COLEMAN KIRK ALLEN (CFO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0.25, valued at
$5k
|
|
| 03/24/2023 |
4
| COLEMAN KIRK ALLEN (CFO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.8, valued at
$80k
|
|
| 03/13/2023 |
4
| COLEMAN KIRK ALLEN (CFO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 12,000 shares
@ $0.7881, valued at
$9.5k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2020 |
4
| COLEMAN KIRK ALLEN (CFO, Secretary and Treasurer) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $15.24, valued at
$152.4k
Exercised 10,000 options to buy
@ $2.5, valued at
$25k
|
|
| 11/13/2020 |
4
| COLEMAN KIRK ALLEN (CFO, Secretary, and Treasurer) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 15,000 shares
@ $15.117, valued at
$226.8k
Exercised 15,000 options to buy
@ $2.5, valued at
$37.5k
|
|
| 08/26/2020 |
4
| COLEMAN KIRK ALLEN (CFO, Secretary, and Treasurer) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $13.65, valued at
$546k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| COLEMAN KIRK ALLEN (CFO, Secretary, and Treasurer) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 5,920 options to buy
@ $5, valued at
$29.6k
|
|
| 10/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|